Scarica l'app Stockscreener
2.695
0.16%
0.00
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AVXL Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$2.695
Aprire:
$2.69
Volume 24 ore:
467.51K
Relative Volume:
0.35
Capitalizzazione di mercato:
$249.75M
Reddito:
-
Utile/perdita netta:
$-39.95M
Rapporto P/E:
-5.7969
EPS:
-0.4649
Flusso di cassa netto:
$-34.08M
1 W Prestazione:
+1.10%
1M Prestazione:
-19.18%
6M Prestazione:
-30.07%
1 anno Prestazione:
-64.15%
Intervallo 1D:
$2.69
$2.80
Intervallo di 1 settimana:
$2.635
$2.80
Portata 52W:
$2.61
$13.99
Anavex Life Sciences Corp Stock (AVXL) Company Profile
Nome
Anavex Life Sciences Corp
Settore
Industria
Telefono
844-689-3939
Indirizzo
630 5TH AVENUE, NEW YORK
Compare AVXL vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AVXL
Anavex Life Sciences Corp
|
2.695 | 249.75M | 0 | -39.95M | -34.08M | -0.4649 |
VRTX
Vertex Pharmaceuticals Inc
|
437.23 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
638.14 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
805.38 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
296.77 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.17 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Anavex Life Sciences Corp Stock (AVXL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-12-06 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-23 | Iniziato | Berenberg | Buy |
| 2021-09-23 | Iniziato | BTIG Research | Buy |
| 2020-12-16 | Reiterato | H.C. Wainwright | Buy |
| 2020-09-28 | Iniziato | Ladenburg Thalmann | Buy |
| 2020-02-27 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-06-18 | Iniziato | Janney | Buy |
| 2018-05-16 | Ripresa | Maxim Group | Buy |
| 2018-03-08 | Iniziato | ROTH Capital | Buy |
| 2018-02-13 | Reiterato | Maxim Group | Buy |
| 2017-09-29 | Ripresa | Noble Financial | Buy |
| 2017-02-07 | Iniziato | Noble Financial | Buy |
| 2016-03-29 | Iniziato | FBR Capital | Outperform |
Mostra tutto
Anavex Life Sciences Corp Borsa (AVXL) Ultime notizie
Anavex Life Sciences (AVXL) Faces Nasdaq Compliance Challenge - GuruFocus
Anavex (AVXL) Faces Nasdaq Notification Due to Filing Delay - GuruFocus
Anavex Life Sciences receives Nasdaq delisting warning - Investing.com UK
Anavex Life Sciences receives Nasdaq delisting warning By Investing.com - Investing.com South Africa
symbol__ Stock Quote Price and Forecast - CNN
Anavex Life Sciences receives expected Nasdaq delinquency notification - marketscreener.com
Anavex Life Sciences Received Notice of Noncompliance - TradingView
Nasdaq warns Anavex (Nasdaq: AVXL) over delayed quarterly filing - Stock Titan
Anavex Life Sciences Corp. Receives Delinquency Notification from Nasdaq for Non-Compliance with Listing Rule - Quiver Quantitative
Anavex Life Sciences Receives Expected Nasdaq Delinquency Notification - Anavex Life Sciences
Nasdaq flags Anavex for missing 10-Q, gives July 20 fix date - Stock Titan
AVXL Stock Price, Quote & Chart | ANAVEX LIFE SCIENCES CORP (NASDAQ:AVXL) - ChartMill
Anavex Life Sciences stock crushed as European Alzheimer's drug filing pulled after EMA pushback - MSN
Anavex Life Sciences Announces COO Departure Amid Restructuring - The Globe and Mail
Anavex (AVXL) COO exits amid reorganization; option grant largely forfeited - Stock Titan
Anavex (AVXL) interim CEO discloses detailed stock option grants - Stock Titan
Anavex withdraws EU approval filing for Alzheimer’s therapy - MSN
Anavex Stock Just Logged Its Worst Selloff In 2 Years — What Does EMA’s Oral Explanation Week Mean For Its Alzheimer’s Drug? - MSN
AVXL stock tanks after Anavex withdraws EU bid for Alzheimer's drug - MSN
Anavex Delays Quarterly Filing Amid CEO Shake-Up - The Globe and Mail
TradingKey - TradingKey
Anavex Life Sciences (AVXL) Delays Quarterly Report Submission - GuruFocus
AVXL SEC FilingsAnavex Life Scie 10-K, 10-Q, 8-K Forms - Stock Titan
Anavex Life Sciences (NASDAQ: AVXL) delays 10-Q after CEO termination - Stock Titan
MSN Money - MSN
Anavex Life Sciences Corp. (AVXL) Stock Analysis: Exploring A 605% Upside Potential - DirectorsTalk Interviews
Biopharma veteran takes her CEO Cue—Chutes & Ladders - Fierce Biotech
Anavex (AVXL) Appoints Interim CEO Amid Leadership Change - GuruFocus
Anavex Life Sciences Names Interim CEO Amid Leadership Shift - The Globe and Mail
Number of shareholders of Anavex Life Sciences Corp. – FWB:12X1 - TradingView
Anavex Life Sciences Appoints Terrie Kellmeyer as Interim CEO Following Christopher Missling’s Departure - Minichart
Anavex appoints interim CEO following leadership change - Investing.com UK
CEO Transition and Delayed SEC Filing Put Anavex (AVXL) Leadership Changes in Focus - Yahoo Finance
Anavex stock slips after CEO transition (AVXL:NASDAQ) - Seeking Alpha
Anavex appoints interim CEO following leadership change By Investing.com - Investing.com India
CEO ousted as Anavex (NASDAQ: AVXL) board installs interim chief and eyes 10-Q delay - Stock Titan
Anavex Life Sciences (AVXL) to Release Earnings on Tuesday - MarketBeat
H.C. Wainwright initiates Anavex Life Sciences stock with buy rating - Investing.com UK
H.C. Wainwright initiates Anavex Life Sciences stock with buy rating By Investing.com - Investing.com South Africa
Director Axel Paeger files initial Form 3 for Anavex (AVXL) - Stock Titan
Anavex Life Sciences Corp Azioni (AVXL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Anavex Life Sciences Corp Azioni (AVXL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Thomas Steffen | Director |
Jun 05 '25 |
Option Exercise |
1.76 |
50,000 |
88,000 |
55,000 |
2.25%
0.46%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):